Adrian Rawcliffe's Net Worth

$1.46 Million

Estimate Recalculated Aug 23, 2024 05:01PM EST

Who is Adrian Rawcliffe?

Adrian Rawcliffe has an estimated net worth of $1.46 Million. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, Wave Life Sciences Ltd., and HUMAN GENOME SCIENCES INC.

SEC CIK

Adrian Rawcliffe's CIK is 0001555851

Past Insider Trading and Trends

2019 was Adrian Rawcliffe's most active year for acquiring shares with 7 total transactions. Adrian Rawcliffe's most active month to acquire stocks was the month of December. 2022 was Adrian Rawcliffe's most active year for disposing of shares, totalling 6 transactions. Adrian Rawcliffe's most active month to dispose stocks was the month of December. 2022 saw Adrian Rawcliffe paying a total of $0.00 for 5,758,704 shares, this is the most they've acquired in one year. In 2018 Adrian Rawcliffe cashed out on 600,000 shares for a total of $1,026,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.2401

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-40.05%
-39.38K
$0.73
-$27,594.00
58.95K
Jan 16 - Jan 17
Form 4
—
0
—
—
0
Jan 15
Form 4
-39.47%
-29.20K
$0.85
-$24,733.58
44.78K
Jan 11 - Jan 12
Form 4
-41.06%
-2.40K
$0.78
-$1,874.34
3.45K
Sep 1
Form 4
-39.87%
-2.33K
$0.92
-$2,146.36
3.52K
Jun 27
Form 4
-42.96%
-10.06K
$1.86
-$18,685.91
13.35K
Jan 17
Form 4
—
0
—
—
0
Jan 17
Form 4
-42.99%
-31.80K
$1.73
-$54,791.45
42.18K
Jan 11 - Jan 12
Form 4
-43.34%
-5.07K
$1.69
-$8,593.66
6.63K
Jan 4
Form 4
-43.34%
-2.54K
$1.97
-$4,993.13
3.32K
Sep 1
Form 4
-43.78%
-2.56K
$1.63
-$4,176.06
3.29K
Jun 27
Form 4
-47.40%
-11.10K
$3.19
-$35,416.21
12.31K
Jan 18
Form 4
-47.38%
-17.41K
$3.55
-$61,876.66
19.33K
Jan 11 - Jan 12
Form 4
—
0
—
—
0
Jan 12
Form 4
-47.27%
-5.53K
$4.06
-$22,483.15
6.17K
Jan 4
Form 4
-47.54%
-2.78K
$5.20
-$14,452.49
3.07K
Sep 1
Form 4
-47.74%
-2.79K
$4.37
-$12,209.78
3.06K
Jun 28
Form 4
-42.20%
-9.88K
$5.67
-$56,008.99
13.53K
Jan 19
Form 4
-42.28%
-2.71K
$6.15
-$16,654.01
3.69K
Jan 12
Form 4
—
0
—
—
0
Jan 11
Form 4
-42.44%
-4.97K
$5.33
-$26,463.68
6.74K
Jan 4
Form 4
-47.44%
-2.78K
$8.51
-$23,637.36
3.08K
Sep 1
Form 4
-47.64%
-2.79K
$9.25
-$25,789.00
3.06K
Aug 3
Form 4
—
0
—
—
0
Jan 16
Form 4
-50.55%
-3.24K
$5.13
-$16,615.89
3.17K
Jan 14
Form 4
-50.41%
-5.90K
$1.20
-$7,080.00
5.8K
Jan 6
Form 4
—
0
—
—
0
Sep 1
Form 4
—
0
—
—
0
Jun 27
Form 4
-48.17%
-3.08K
$5.37
-$16,559.23
3.32K
Jan 14
Form 4
—
0
—
—
0
Jan 4
Form 4
-100.00%
-600.00K
$1.71
-$1,026,000.00
0
Mar 20
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Jan 13
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found

Wave Life Sciences Ltd. (WVE) Snapshot price: $4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
16.11K
—
—
16.11K
Aug 12
Form 4
—
0
—
—
0
Aug 7
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Aug 18
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Aug 13
Form 4
—
0
—
—
0
Aug 10
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

HUMAN GENOME SCIENCES INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found